Ingredient Guide
Banaba Leaf: Benefits, Dosage, and What the Research Says
The tropical leaf behind corosolic acid - what human research actually shows
Written by Jessica Medson
Banaba leaf (Lagerstroemia speciosa L.) is a tropical tree native to the Philippines and Southeast Asia whose leaves have been used in folk medicine for centuries to help maintain healthy blood sugar levels. Its primary bioactive compound, corosolic acid, promotes cellular glucose uptake by stimulating GLUT4 transporter translocation to the cell surface and may also slow dietary carbohydrate absorption. Human clinical trials are small but consistent: a placebo-controlled trial (n=31) found that 10 mg of corosolic acid significantly reduced post-glucose-challenge blood sugar at the 90-minute mark compared with placebo, and a 2022 randomized trial in patients with metabolic syndrome reported meaningful glycemic improvements after 12 weeks of 500 mg banaba extract taken twice daily.
What Is Banaba Leaf?
Banaba (Lagerstroemia speciosa L.) is a tropical flowering tree native to the Philippines, India, and Southeast Asia. For centuries, folk healers in the Philippines have brewed its leaves as a tea to support healthy blood sugar levels, a practice documented as far back as indigenous Filipino herbal traditions and noted in the first Western scientific publication on the subject in 1940.
The leaves contain two principal classes of bioactive compounds:
- Corosolic acid - a pentacyclic triterpene and the most widely studied constituent in modern research
- Ellagitannins - including lagerstroemin, flosin B, reginin A, and the gallotannin penta-O-galloyl-glucopyranose (PGG)
Commercial banaba supplements are typically standardized to 1% corosolic acid by weight, though higher-concentration extracts and isolated corosolic acid products also exist. The 1% standardization has been the most commonly used format in human clinical research to date.1
Not to be confused with banana leaf. Banaba (Lagerstroemia speciosa) and banana (Musa species) come from entirely different plant families and have no shared bioactive compounds.
How Does Banaba Leaf Work?
Research points to several complementary mechanisms through which banaba leaf compounds may influence glucose and fat metabolism:
- GLUT4 translocation: Corosolic acid promotes movement of glucose transporter type 4 (GLUT4) protein from intracellular storage compartments to the muscle cell surface, allowing circulating glucose to enter cells without requiring additional insulin output. This has been demonstrated in animal models with single oral doses.6
- Insulin receptor sensitization: In cell-based studies, corosolic acid enhanced phosphorylation of the insulin receptor beta-subunit and downstream signaling proteins (IRS-1, Akt), effectively amplifying insulin signaling. This effect was independent of changes in insulin secretion in animal experiments.6
- Carbohydrate enzyme inhibition: Banaba compounds appear to slow the activity of alpha-glucosidase and alpha-amylase, the intestinal enzymes responsible for breaking down starches and sucrose into absorbable glucose. This blunts the post-meal glucose rise in a mechanism similar to pharmaceutical alpha-glucosidase inhibitors.1
- Reduced hepatic gluconeogenesis: Preclinical data suggest corosolic acid may suppress glucose production in the liver, a recognized target of pharmaceutical diabetes management strategies.1
- PPAR activation: In obese animal models, corosolic acid activated PPAR-alpha in the liver and PPAR-gamma in adipose tissue - pathways central to lipid metabolism and insulin sensitivity - and raised circulating adiponectin levels.7
- Anti-adipogenic effects (ellagitannins): Cell culture work showed that PGG, a gallotannin in banaba leaves, simultaneously stimulated glucose uptake and inhibited fat cell (adipocyte) differentiation - a dual action not typically seen in single-mechanism insulin mimetics.5
This multi-target profile is scientifically interesting, but it is worth noting that most mechanism work is from cell lines and animal models. Confirming which pathways operate at practical doses in humans remains an active research priority.
Blood Sugar and Glycemic Support
The most clinically studied application of banaba leaf is supporting healthy blood glucose levels within the normal range, particularly in individuals with mildly elevated fasting glucose or features of metabolic syndrome.
What the research shows
A randomized, placebo-controlled clinical trial published in Diabetes Research and Clinical Practice enrolled 31 participants who received either 10 mg of 99%-pure corosolic acid or placebo before a standard oral glucose challenge. The corosolic acid group showed statistically significantly lower blood glucose readings from 60 to 120 minutes post-challenge, reaching significance at 90 minutes compared with placebo.2 This remains one of the clearest human demonstrations that corosolic acid can attenuate postprandial glucose elevations.
A 2022 randomized, double-blind, placebo-controlled trial evaluated 500 mg of banaba extract (taken twice daily, before breakfast and dinner) in 24 patients with metabolic syndrome over 12 weeks. Researchers assessed fasting plasma glucose, area under the curve for glucose and insulin during an oral glucose tolerance test, insulin sensitivity, and insulin secretion phases. The banaba group showed improvements in these glycemic parameters compared with placebo, adding to the human evidence for this ingredient.3
Earlier review work synthesizing multiple small human trials reported average blood glucose reductions in the range of 13.5% to 30% across studies in subjects with mildly elevated fasting glucose, depending on extract form, corosolic acid dose, and duration.1
Important limitations
Individual human trials in this area are small (10 to 31 participants), short-term (2 to 12 weeks), and heterogeneous in study design, extract type, and dose. None to date have been multi-site or adequately powered for regulatory-grade conclusions. These results are consistently directional but should not be read as equivalent to approved therapy for managing blood sugar disorders.
Weight Management and Metabolic Health
Beyond glycemic effects, banaba leaf compounds have been studied for their potential influence on body composition and broader markers of metabolic health.
What the research shows
In obese KK-Ay mice (a genetic model of type 2 diabetes and metabolic syndrome), nine weeks of dietary corosolic acid supplementation produced a 10% lower body weight, 15% lower total fat mass, 23% reduction in fasting glucose, 41% reduction in fasting insulin, and 22% reduction in triglycerides compared with unsupplemented controls.7 The researchers attributed these outcomes to increased plasma adiponectin and enhanced PPAR-alpha and PPAR-gamma expression in liver and adipose tissue respectively - findings that offer a plausible biological rationale for the metabolic effects.7
At the cellular level, the gallotannin PGG from banaba leaves has demonstrated in cell culture the ability to simultaneously stimulate glucose uptake and inhibit the differentiation of pre-fat cells into mature adipocytes, a combination of activities not commonly found in single-ingredient glucose-support compounds.5
A 60-day human pilot study evaluated a combination supplement containing banaba leaf extract alongside green coffee bean extract, Moringa oleifera, and vitamin D3. Participants showed statistically significant decreases in fat mass (p=0.004) and increases in fat-free mass (p=0.009) compared with a historical placebo cohort, with no adverse changes in blood chemistry or metabolic markers.4 Because this was a multi-ingredient formula tested against a historical (not concurrent) control, banaba's individual contribution to these outcomes cannot be separated from the formula as a whole.
Current evidence limitations
No large-scale, banaba-specific human RCT has examined weight or fat loss as a primary endpoint. Current evidence from animal models is compelling mechanistically, and early human data are encouraging, but are insufficient to support body composition claims for the general population.
Anti-Inflammatory and Antioxidant Properties
A growing body of preclinical work has investigated corosolic acid as a multi-target anti-inflammatory and antioxidant compound.
What the research shows
Review analyses highlight that corosolic acid modulates several key inflammatory signaling pathways, including NF-kB, PI3K/Akt, and IRAK-1. In cell and animal studies, it has suppressed pro-inflammatory mediators including MCP-1, IL-1beta, and NLRP3 inflammasome components.8 Antioxidant activity has also been reported, with corosolic acid reducing markers of oxidative stress in preclinical models - consistent with the broader pharmacological profile described in mechanistic reviews.1
The relevance to metabolic health is that chronic low-grade inflammation is closely linked to insulin resistance, and the compound's dual action on glucose metabolism and inflammatory signaling pathways may represent complementary support mechanisms.8
Tier of evidence: Preclinical only. Anti-inflammatory and antioxidant effects of corosolic acid have not been confirmed in published human clinical trials. This section reflects cell-based and animal model research. Human studies are needed before any conclusions can be drawn about these effects in people.
Safety, Side Effects, and Interactions
Banaba leaf extract and corosolic acid have demonstrated a favorable safety profile across the clinical trials conducted to date. No serious adverse events were reported in multiple human studies, including one year of supplementation in a small observational cohort and a 60-day controlled pilot study where all blood chemistry markers remained unchanged.14 That said, high-quality long-term safety data in large, diverse populations are not yet available.
Potential side effects
- Mild gastrointestinal symptoms: Some individuals may experience upset stomach, dizziness, or headache. These effects were not observed at clinically meaningful rates in controlled trials but have been noted in post-market reports.
- Low blood sugar (hypoglycemia): Because banaba may support lower blood glucose levels, individuals already taking glucose-lowering medications could experience additive effects. Symptoms of hypoglycemia include shakiness, sweating, confusion, and rapid heartbeat.
Drug interactions
- Antidiabetic medications (metformin, sulfonylureas, GLP-1 agonists, insulin): Additive blood-sugar-lowering effects are plausible. Do not combine with prescription diabetes therapy without informing your healthcare provider and arranging appropriate glucose monitoring.
- Antihypertensive medications: Preliminary data suggest corosolic acid may influence blood pressure; combining with antihypertensive drugs may warrant monitoring.
- Herbs and supplements with blood sugar effects: Stacking banaba with berberine, chromium, bitter melon, or cinnamon may compound glucose-lowering activity. Use caution and monitor blood glucose if combining.
Special populations
- Pregnancy and breastfeeding: There is insufficient safety data for banaba leaf during pregnancy or while breastfeeding. Avoid use unless directed by a qualified healthcare provider.
- Surgical patients: Because banaba may affect blood glucose regulation, general practice recommends discontinuing blood-sugar-affecting supplements at least two weeks before scheduled surgery. Discuss with your surgical team.
- Children: Banaba leaf has not been evaluated in pediatric populations. Use in children is not established and is not recommended.
Banaba Leaf Dosage Reference
The following doses reflect what was used in published human clinical trials. No single optimal dose has been established; consult a healthcare provider to determine what is appropriate for your situation.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Postprandial blood glucose support | 10 mg isolated corosolic acid (99% purity) | Before a meal or glucose challenge | Dose used in Fukushima et al. 2006 RCT (n=31); statistically significant glucose reduction at 90 minutes post-challenge vs. placebo |
| Metabolic syndrome glycemic support | 500 mg standardized banaba extract (1% corosolic acid) - twice daily | Before breakfast and before dinner | Dose and schedule used in Lopez-Murillo et al. 2022 RCT (n=24, 12 weeks); improvements in insulin sensitivity parameters |
| General glycemic support (early study protocols) | 32-48 mg standardized banaba extract (1% corosolic acid) | With meals | Range used in earlier small human trials summarized in Stohs et al. 2012 review; reported 13.5%-30% glucose reductions in subjects with mildly elevated baseline |
Doses are reported for educational purposes only. They do not constitute medical advice and have not been approved by the FDA to prevent or treat any condition.
What the Evidence Shows at a Glance
A summary of banaba leaf research outcomes by evidence strength. Tier A = human RCT or meta-analysis; Tier B = human observational or pilot data; Tier C = animal or cell models only.
| Outcome | What Studies Show | Evidence Strength |
|---|---|---|
| Postprandial blood glucose | 10 mg corosolic acid significantly reduced post-challenge glucose AUC at 90 min vs. placebo in 31 subjects | Tier A - Human RCT |
| Fasting blood glucose | Reviews synthesizing multiple small human trials report 13.5%-30% reductions in subjects with mildly elevated fasting glucose | Tier B - Small human trials |
| Insulin sensitivity | 500 mg banaba extract twice daily improved OGTT-based glycemic parameters in 24 metabolic syndrome patients over 12 weeks | Tier A - Human RCT |
| Body weight and fat mass | 10% lower body weight and 15% lower fat mass in obese mouse models; limited multi-ingredient human pilot data | Tier C (animal); Tier B (multi-ingredient human pilot) |
| Blood triglycerides | 22% lower fasting triglycerides in obese mouse models; no direct human lipid endpoint trial confirmed | Tier C - Animal study only |
| Anti-inflammatory effects | NF-kB inhibition, reduced IL-1beta and NLRP3 activity in cell and animal models; no confirmed human trial | Tier C - Preclinical only |
| Antioxidant activity | Reduced oxidative stress markers in preclinical models; mechanism plausible but untested in humans | Tier C - Preclinical only |
This table reflects published research findings, not product claims. Results from animal and cell studies may not translate to humans.
Frequently Asked Questions
What is Banaba Leaf good for?
Banaba leaf is most studied for supporting healthy blood glucose levels within the normal range. Its active compound, corosolic acid, helps cells take up glucose more efficiently by promoting GLUT4 transporter activity. Early human research also suggests potential benefits for insulin sensitivity and metabolic syndrome markers. Anti-inflammatory and body composition effects have been shown in preclinical studies but are not yet confirmed in human trials.
How much Banaba Leaf should I take?
Human trials have used doses ranging from 10 mg of isolated corosolic acid (taken before meals) to 500 mg of standardized banaba extract (1% corosolic acid) taken twice daily. The 500 mg twice-daily dose was used in a 2022 randomized controlled trial lasting 12 weeks. No regulatory authority has established an official recommended dose; consult a healthcare provider before starting.
Does Banaba Leaf lower blood sugar?
Clinical research suggests banaba leaf extract may help maintain blood glucose within the normal range. One placebo-controlled human trial (n=31) found that 10 mg of corosolic acid produced significantly lower glucose readings at 90 minutes after a glucose challenge. Results across small trials suggest reductions of 13.5% to 30% in people with mildly elevated fasting glucose. These findings are promising but come from small studies and are not sufficient for medical claims.
What does corosolic acid do?
Corosolic acid is a pentacyclic triterpene that promotes glucose entry into muscle cells by stimulating the GLUT4 transporter, enhances insulin receptor signaling, inhibits carbohydrate-digesting enzymes, and may reduce hepatic glucose production. In animal studies it also activates PPAR pathways involved in lipid metabolism. It is the primary bioactive compound studied in banaba leaf supplements and is responsible for most of the glycemic research findings.
Is Banaba Leaf safe?
Banaba leaf extract has a favorable safety record in published clinical trials, with no serious adverse events reported across studies lasting up to one year. Mild side effects (upset stomach, dizziness, headache) are occasionally noted. The main safety concern is additive blood-sugar lowering when combined with diabetes medications. It should be avoided during pregnancy and breastfeeding due to a lack of safety data in those populations.
Can Banaba Leaf help with weight loss?
Preclinical animal research is intriguing: obese mice given corosolic acid for nine weeks showed 10% lower body weight and 15% lower fat mass versus controls. A multi-ingredient human pilot study including banaba leaf found statistically significant decreases in fat mass over 60 days. However, no large, banaba-specific human RCT has tested weight loss as a primary endpoint, so the current evidence is insufficient to support weight-loss claims for human use.
What are the side effects of Banaba Leaf?
Controlled clinical trials have reported no serious adverse effects. Potential side effects noted in post-market experience include mild gastrointestinal upset, dizziness, and headache. The most clinically relevant concern is low blood sugar (hypoglycemia) when banaba is combined with antidiabetic medications. Individuals on blood-pressure medications should also monitor for possible additive effects, based on limited preliminary data.
Can I take Banaba Leaf if I have diabetes?
Most human research on banaba leaf has been conducted in people with prediabetes or metabolic syndrome, not in people with a formal diabetes diagnosis who are on prescription therapy. Because banaba may add to the blood-sugar-lowering effect of metformin, sulfonylureas, insulin, or GLP-1 agonists, combining these creates a potential hypoglycemia risk. Always consult your prescriber before adding any supplement to a diabetes management regimen.
How long does Banaba Leaf take to work?
Effects on post-meal blood glucose can be observed within 60 to 90 minutes of ingestion based on the Fukushima 2006 clinical trial data, suggesting a relatively rapid onset for the glucose-blunting effect. Broader metabolic benefits, such as improvements in insulin sensitivity, appear to require consistent use over several weeks; the Lopez-Murillo 2022 trial ran for 12 weeks before significant glycemic parameter improvements were measured.
Is Banaba Leaf the same as banana leaf?
No. Banaba (Lagerstroemia speciosa) and banana (Musa species) are completely unrelated plants from different botanical families. They share no meaningful bioactive compounds. Banaba is sometimes sold as "banaba leaf extract" or "corosolic acid," which can cause confusion. Banana leaves are used in cooking and food preparation; they have not been studied for blood sugar effects.
Shop Banaba Leaf
HealthFare Banaba Leaf supplements
Scientific References
- 1.Stohs SJ, Miller H, Kaats GR A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytotherapy Research. 2012. PubMed: 22095937Human observational
- 2.Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Research and Clinical Practice. 2006. PubMed: 16549220Clinical (RCT / meta-analysis)
- 3.Lopez-Murillo LD, Gonzalez-Ortiz M, Martinez-Abundis E, Cortez-Navarrete M, Perez-Rubio KG Effect of Banaba (Lagerstroemia speciosa) on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. Journal of Medicinal Food. 2022. PubMed: 34726501Clinical (RCT / meta-analysis)
- 4.Stohs SJ, Kaats GR, Preuss HG Safety and Efficacy of Banaba-Moringa oleifera-Green Coffee Bean Extracts and Vitamin D3 in a Sustained Release Weight Management Supplement. Phytotherapy Research. 2016. PubMed: 26871553Human observational
- 5.Klein G, Kim J, Himmeldirk K, Cao Y, Chen X Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa. Evidence-Based Complementary and Alternative Medicine. 2007. PubMed: 18227906Preclinical (animal / cell)
- 6.Miura T, Itoh Y, Kaneko T, Ueda N, Ishida T, Fukushima M, Matsuyama F, Seino Y Corosolic acid induces GLUT4 translocation in genetically type 2 diabetic mice. Biological and Pharmaceutical Bulletin. 2004. PubMed: 15256748Preclinical (animal / cell)
- 7.Yamada K, Hosokawa M, Yamada C, Watanabe R, Fujimoto S, Fujiwara H, Kunitomo M, Miura T, Kaneko T, Tsuda K, Seino Y, Inagaki N Dietary corosolic acid ameliorates obesity and hepatic steatosis in KK-Ay mice. Biological and Pharmaceutical Bulletin. 2008. PubMed: 18379057Preclinical (animal / cell)
- 8.Zhao J, Zhou H, An Y, Shen K, Yu L Biological effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and anti-neoplasic natural compound. Oncology Letters. 2021. PubMed: 33363621Human observational